| Christopher M Kellogg, MD | |
|
695 S Dobson Rd, Chandler, AZ 85224-5665 | |
| (480) 821-2838 | |
| (480) 821-9444 |
| Full Name | Christopher M Kellogg |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 38 Years |
| Location | 695 S Dobson Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740254457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 23612 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ironwood Physicians Pc | 3577454842 | 101 |
News Archive
Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.
The research, which was published in the journal Health Affairs, used new tools to find that as many as one in three people in the U.S. will experience some type of mistake during a hospital stay. Also, the findings estimate the number of actual hospital errors to be as much as 10 times higher than found by voluntary reporting programs.
Vaccine passports raise questions of equity, security, privacy, argues Crispin Maslog. China, where the COVID-19 pandemic began a long year ago, has now become the first country in the world to issue a vaccine passport to promote world economic recovery and facilitate cross-border travel.
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
News outlets covered a range of developments including workforce issues in Minnesota and California, and a Kentucky order for insurers to provide child-only policies.
› Verified 9 days ago
| Entity Name | Ironwood Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740269299 PECOS PAC ID: 3577454842 Enrollment ID: O20040324000807 |
News Archive
Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.
The research, which was published in the journal Health Affairs, used new tools to find that as many as one in three people in the U.S. will experience some type of mistake during a hospital stay. Also, the findings estimate the number of actual hospital errors to be as much as 10 times higher than found by voluntary reporting programs.
Vaccine passports raise questions of equity, security, privacy, argues Crispin Maslog. China, where the COVID-19 pandemic began a long year ago, has now become the first country in the world to issue a vaccine passport to promote world economic recovery and facilitate cross-border travel.
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
News outlets covered a range of developments including workforce issues in Minnesota and California, and a Kentucky order for insurers to provide child-only policies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher M Kellogg, MD Po Box 6423, Chandler, AZ 85246-6423 Ph: () - | Christopher M Kellogg, MD 695 S Dobson Rd, Chandler, AZ 85224-5665 Ph: (480) 821-2838 |
News Archive
Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.
The research, which was published in the journal Health Affairs, used new tools to find that as many as one in three people in the U.S. will experience some type of mistake during a hospital stay. Also, the findings estimate the number of actual hospital errors to be as much as 10 times higher than found by voluntary reporting programs.
Vaccine passports raise questions of equity, security, privacy, argues Crispin Maslog. China, where the COVID-19 pandemic began a long year ago, has now become the first country in the world to issue a vaccine passport to promote world economic recovery and facilitate cross-border travel.
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
News outlets covered a range of developments including workforce issues in Minnesota and California, and a Kentucky order for insurers to provide child-only policies.
› Verified 9 days ago
Dr. Jaskanwal Singh Bisla, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-428-5500 | |
Dr. Naga Nalini Tirumalasetty, MD,ECNU,FACE. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 908 W Chandler Blvd Ste 4, Chandler, AZ 85225 Phone: 480-269-6448 Fax: 779-204-2331 | |
Amer Al-khoudari, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 604 W Warner Rd Ste C1, Chandler, AZ 85225 Phone: 480-372-8200 Fax: 480-372-8222 | |
Bidya Lohani-sharma, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 845 E Warner Rd Ste 101, Chandler, AZ 85225 Phone: 480-786-5000 Fax: 480-786-5050 | |
Nisar Ahmed, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Chuck Stephen Mangubat, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Dr. Edward Markman, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-926-0170 |